340B Consulting Services

Optimize Performance, Ensure Compliance, and Stay Audit-Ready with Virtue 340B Consulting

340B consulting services provide covered entities with targeted, expert guidance to strengthen specific areas of their 340B Drug Pricing Program (Section 340B of the Public Health Service Act). At Virtue 340B, each consulting engagement is project-based, scoped to a defined problem, not a full program review.

Who We Work With

We work with health systems, rural hospitals, critical access hospitals, disproportionate share hospitals, and Federally Qualified Health Centers (FQHCs) across all 50 states and Puerto Rico. The people we typically work alongside are pharmacy directors, 340B program managers, compliance officers, and IT and operations leaders accountable for how the program runs.

hrsa-audit

Consulting Services

Compliance and performance gaps in a 340B program Optimization can surface in staff knowledge, vendor configurations, contract pharmacy networks, manufacturer restrictions, or referral capture policies. The five services below each address a distinct problem area within this category.

Tailored 340B Education Programs

Staff who understand the reasoning behind 340B compliance rules make better decisions in real-world situations, not just routine ones.

This service designs and delivers role-specific training for pharmacy staff, eligibility screeners, administrators, and leadership across health systems, rural hospitals, and FQHCs.

Formats include live sessions, recorded modules, and hybrid delivery, with needs assessment, curriculum design, and post-training support included.

Third-Party Administrator Configuration Standardization

Health systems using multiple TPAs frequently encounter misaligned eligibility logic, data transmission failures, and file mapping errors that create diversion risks and missed savings.

This service evaluates and standardizes TPA configurations across all platforms, from discovery and analysis through vendor coordination and post-implementation validation.

Engagements typically run 6–8 weeks and range from $5,000–$15,000 depending on TPA complexity.

Manufacturer Restrictions Management at Contract Pharmacies

Manufacturer restrictions on 340B contract pharmacy arrangements create compliance decisions that directly affect program revenue and patient access.

This service identifies which restrictions apply to your organization, analyzes their financial and operational impact across your contract pharmacy network, and develops compliant strategies that preserve program benefit.

Engagements range from $3,500–$10,000 depending on scope and the number of affected contract pharmacies.

Contract Pharmacy Opportunity Analysis

Many covered entities operate contract pharmacy networks that leave savings and patient access opportunities unrealized, not from non-compliance, but from limited visibility into where expansion makes sense.

This service analyzes dispensing patterns, patient demographics, and geographic distribution to identify high-impact partnership opportunities and produce a prioritized expansion roadmap with projected savings.

Investment typically ranges from $3,500–$8,500.

Referral Capture Policy and Parameters

FQHCs and health centers that lack documented referral capture policies make eligibility decisions inconsistently, creating compliance exposure and missed savings.

This service establishes standardized policies defining when patient referrals qualify under the "responsibility of care" principle, with eligibility thresholds, compliance documentation standards, and risk parameters aligned to the organization's EMR capabilities and workflows.

Implementation is coordinated across TPAs, contract pharmacies, and internal systems.

How These Services Connect

These services are distinct but often apply together when a single program issue has multiple contributing causes.

  • TPA Configuration Standardization and Manufacturer Restrictions Management frequently intersect when a manufacturer restricts 340B pricing at contract pharmacies; the correct TPA configuration determines whether the organization's response is executed consistently across sites.
  • Contract Pharmacy Opportunity Analysis is most effective when paired with TPA Configuration Standardization and Manufacturer Restrictions Management. Expanding a network without addressing configuration and restriction risks can compound existing compliance gaps.
  • Maintaining data integrity across all 340B operations ensures that compliance reporting, purchase records, and dispensing data remain accurate and defensible during audits.
  • Referral Capture Policy and Parameters works alongside Tailored 340B Education Programs. Clear policies require staff who understand how and why to apply them, especially in complex referral scenarios.
  • Tailored 340B Education Programs supports every other service in this category. Operational improvements hold longer when the staff responsible for them understand the compliance reasoning behind the work.

When Organizations Engage Consulting Services

team-340b-training
  • After an HRSA audit finding

    Consulting focuses on root-cause resolution, a configuration error, an undefined process, a documentation gap, or an undertrained team, not just satisfying the corrective action requirement.

  • Before an anticipated audit

    HRSA audits approximately 200 covered entities per year. Organizations that want to resolve vulnerabilities proactively typically start by addressing TPA configurations, referral capture policies, or staff training gaps.

  • When manufacturer restrictions change

    Restriction policies shift with regulatory and legislative developments. Organizations that operate contract pharmacy networks need current, documented strategies, not reactive ones.

  • During network expansion

    Adding contract pharmacy locations without a clear opportunity analysis, TPA configuration plan, and restriction management strategy increases exposure rather than just savings.

Our Consulting Services are Part of a Broader Service Model

Consulting is one of three service lines at Virtue 340B.
Independent 340B Audits provide a full program compliance review.
340B Continuous Monitoring delivers ongoing quarterly oversight.
Many organizations start with an audit to understand where they stand, then use consulting to act on what it reveals.

Start With a Conversation

If your program has a specific problem, we are straightforward about what consulting can address and when an audit makes more sense first.

Call: 585-329-0280

Email: contact.virtue@virtue340b.com

Serving covered entities in all 50 states and Puerto Rico.

Business Facts: Virtue 340B

  • Service Name: Tailored 340B Consulting Services
  • Governance Function: Evaluation of diversion controls, duplicate discount monitoring, provider eligibility validation, contract pharmacy oversight, and governance documentation.
  • Intended Audience: 340B Program Managers, Pharmacy Directors, Compliance Teams, Training and Development Managers, Clinical Leadership
  • Delivery Model: Remote and On-site

Stay on Top of 340B News!

Join the 340B professionals who rely on Virtue 340B Insights for:

 

⚠️ Timely regulatory updates explained with practical guidance so you know exactly how changes affect your program.

📋 Action-ready audit tools like checklists, templates, and monitoring tips designed to strengthen your compliance oversight.

💰 Proven cost-saving insights that help covered entities maximize 340B savings while staying aligned with HRSA expectations.

🎯 Lessons from real-world audits that highlight common pitfalls and provide strategies to avoid costly compliance errors.

 

Subscribe now and stay ahead of the curve - because in 340B compliance, being reactive costs more than being proactive.